OMOlivia J. Marola

Olivia J. Marola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olivia J. Marola has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Crop-OCT: a Fully Integrated Imageomics Pipeline to Identify Regional and Focal Retinopathy in Murine Models

    by Danielle R. Little, Abbas Shirinifard, Marybeth Lupo, Chih-Hsuan Wu, Haoran Chen, Mellisa R. Clemons, Michael Maclean, Olivia J. Marola, Gareth R. Howell, Cai Li, et al.

    Imageomics uses machine learning to accelerate our understanding of biological traits and human disease processes. Some of the earliest imageomics applications used deep learning to assess human diseases. For example, retinal fundus images were analyzed to diagnose diabetic retinopathy. The imaging modality optical coherence tomography (OCT) is widely used to diagnose and monitor the progression of retinopathy in patients and preclinical models. The standardized instrumentation and image format of OCT lends itself to imageomics, but generalizable, automated pipelines for segmentation and quantitation of large numbers of OCT images are still in early development. Here, we present the automated, end-to-end pipeline Crop-OCT that extracts features from thousands of OCT images, while preserving their location within the eye. We used the Crop-OCT pipeline on a diverse dataset, including 13 genetic models of retinopathy, with more than 20,000 OCT images, which allowed us to analyze nearly 6 million measured features. The pipeline was generalized on an independent dataset that was analyzed in a blinded manner. The pipeline enabled us to monitor ocular changes associated with aging and progression of diseases, such as retinitis pigmentosa, Leber congenital amaurosis, achromatopsia, Stargardt disease, diabetic retinopathy, and age-related macular degeneration. We also characterized heterogeneity across animals and identified regional and focal lesions. Our pipeline will unify feature extraction for preclinical models of retinal disease and serve as a foundation for future multimodal data integration for artificial intelligence applications based on imageomics.

  • Open Access

    MKK4 and MKK7 control degeneration of retinal ganglion cell somas and axons after glaucoma-relevant injury

    by Olivia J. Marola, Stephanie B. Syc-Mazurek, Sarah E. R. Yablonski, Peter G. Shrager, Simon W. M. John, Richard T. Libby

    Retinal ganglion cell (RGC) death is a critical component of glaucoma pathology. The degenerative signaling pathways that lead to RGC death in glaucoma are incompletely defined. Recently, the transcription factors JUN and DDIT3 were identified as critical hubs regulating RGC somal loss after mechanical axonal injury. However, their position within the degenerative cascade remains unclear. One possibility is that JUN and DDIT3 activity in the soma initiates signaling events that trigger axonal degeneration. Alternatively, JUN and DDIT3 may function downstream of the primary insult, acting specifically to mediate somal degeneration without influencing axonal pathology. Disentangling these possibilities is critical for understanding the compartment-specific mechanisms of RGC degeneration in glaucoma. The MAP2Ks MKK4 and MKK7 control JNK and JUN activity and can indirectly activate DDIT3. Furthermore, MKK4 and MKK7 have been shown to drive RGC axonal degeneration after mechanical axonal injury. The present work investigated whether JUN and DDIT3, or their upstream activators MKK4 and MKK7, control degeneration of RGC axons and somas after glaucoma-relevant injuries; including ocular hypertension in aged DBA/2J mice and after mechanical axonal injury (controlled optic nerve crush, CONC) in C57BL/6J mice. Ddit3 and Jun deletion did not prevent RGC axonal degeneration in DBA/2J mice but prevented nearly all somal loss. Despite robust somal survival, Ddit3 and Jun deletion did not prevent RGC somal shrinkage or pattern electroretinography (PERG) amplitude decline in DBA/2J mice or after CONC in C57BL/6J mice. In contrast, Mkk4 and Mkk7 deletion from C57BL/6J mice significantly lessened RGC soma and axon degeneration while preserving PERG amplitude and soma size after CONC. In summary, activation of MKK4 and MKK7 may be an inciting mechanism governing RGC somal and axonal degeneration after glaucoma-relevant axonal injury.


  • Open Access

    Optimizing the Characterization and Quantification of Retinal Ganglion Cell Somas in Healthy and Injured Retinas Using Cellpose

    by Sarah E.R. Yablonski, Abigail Bishop, Sean D. Lydon, Ivan Zhu, Nicole Wang, Olivia J. Marola, Richard T. Libby

    Quantification of retinal ganglion cell (RGC) soma number and characterization of somal features are commonly used output metrics for investigation of optic neuropathies. Many investigators still perform these quantifications by hand, which is time consuming and prone to bias. Cellpose is an open-source Python package that can perform cellular segmentation and holds promise for automating somal analyses. Here, we designed a custom script incorporating the Cellpose package and custom-trained Cellpose models that are capable of automatic characterization and quantification of RGC somas. Our script, using our models, is capable of automatically counting RGC somas, along with characterizing RGC somal size. Further, we show that Cellpose can quantify RGCs using multiple cell-type specific markers and has the potential to quantify RGCs across the entire retina. Together, our custom Cellpose models and script which generates and analyzes Cellpose outputs provides a powerful tool for all-in-one RGC somal analysis.

  • Open Access

    MKK4 and MKK7 control degeneration of retinal ganglion cell somas and axons after glaucoma-relevant injury.

    by Olivia Marola, Stephanie Syc-Mazurek, Sarah Yablonski, Peter Shrager, Simon John, Richard Libby

    Glaucoma is characterized by programmed cell death of retinal ganglion cells (RGCs) after axonal injury. Several studies have shown the cell-intrinsic drivers of RGC degeneration act in a compartment-specific manor. Recently, the transcription factors JUN and DDIT3 were identified as critical hubs regulating RGC somal loss after mechanical axonal injury. It is possible somal DDIT3 and JUN activity initiates axonal degeneration mechanisms in glaucoma. Alternatively, DDIT3 and JUN may act downstream of inciting degenerative mechanisms and only drive RGC somal loss. The MAP2Ks MKK4 and MKK7 control all JNK and JUN activity and can indirectly activate DDIT3. Furthermore, MKK4 and MKK7 have been shown to drive RGC axonal degeneration after mechanical axonal injury. The present work investigated whether JUN and DDIT3, or their upstream activators MKK4 and MKK7, control degeneration of RGC axons and somas after glaucoma-relevant injury. Ddit3 and Jun deletion did not prevent axonal degeneration in ocular hypertensive DBA/2J mice but prevented nearly all RGC somal loss. Despite robust somal survival, Ddit3 and Jun deletion did not preserve RGC somal viability (as assessed by PERG decline and soma shrinkage) in DBA/2J mice or after glaucoma-relevant mechanical axonal injury. In contrast, Mkk4 and Mkk7 deletion significantly lessened degeneration of RGC somas and axons, and preserved somal function and size after axonal injury. In summary, activation of MKK4 and MKK7 appears to be the inciting mechanism governing death of the entire RGC after glaucoma-relevant injury; driving death of the RGC soma (likely through activation of DDIT3 and JUN), decline in somal viability, and axonal degeneration via DDIT3 and JUN-independent mechanisms.

  • Open Access

    Genetic context modulates aging and degeneration in the murine retina

    by Olivia J. Marola, Michael MacLean, Travis L. Cossette, Cory A. Diemler, Amanda A. Hewes, Alaina M. Reagan, Jonathan Nyandu Kanyinda, Daniel A. Skelly, Gareth R. Howell

    Background: Age is the principal risk factor for neurodegeneration in both the retina and brain. The retina and brain share many biological properties; thus, insights into retinal aging and degeneration may shed light onto similar processes in the brain. Genetic makeup strongly influences susceptibility to age-related retinal disease. However, studies investigating retinal aging have not sufficiently accounted for genetic diversity. Therefore, examining molecular aging in the retina across different genetic backgrounds will enhance our understanding of human-relevant aging and degeneration in both the retina and brain—potentially improving therapeutic approaches to these debilitating conditions. Methods: Transcriptomics and proteomics were employed to elucidate retinal aging signatures in nine genetically diverse mouse strains (C57BL/6J, 129S1/SvlmJ, NZO/HlLtJ, WSB/EiJ, CAST/EiJ, PWK/PhK, NOD/ShiLtJ, A/J, and BALB/cJ) across lifespan. These data predicted human disease-relevant changes in WSB and NZO strains. Accordingly, B6, WSB, and NZO mice were subjected to human-relevant in vivo examinations at 4, 8, 12, and/or 18M, including: slit lamp, fundus imaging, optical coherence tomography, fluorescein angiography, and pattern/full-field electroretinography. Retinal morphology, vascular structure, and cell counts were assessed ex vivo. Results: We identified common molecular aging signatures across the nine mouse strains, which included genes associated with photoreceptor function and immune activation. Genetic background strongly modulated these aging signatures. Analysis of cell type-specific marker genes predicted age-related loss of photoreceptors and retinal ganglion cells (RGCs) in WSB and NZO, respectively. Fundus exams revealed retinitis pigmentosa-relevant pigmentary abnormalities in WSB retinas and diabetic retinopathy (DR)-relevant cotton wool spots and exudates in NZO retinas. Profound photoreceptor dysfunction and loss were confirmed in WSB. Molecular analyses indicated changes in photoreceptor-specific proteins prior to loss, suggesting photoreceptor-intrinsic dysfunction in WSB. In addition, age-associated RGC dysfunction, loss, and concomitant microvascular dysfunction were observed in NZO mice. Proteomic analyses revealed an early reduction in protective antioxidant processes, which may underlie increased susceptibility to DR-relevant pathology in NZO. Conclusions: Genetic context is a strong determinant of retinal aging, and our multi-omics resource can aid in understanding age-related diseases of the eye and brain. Our investigations identified and validated WSB and NZO mice as improved preclinical models relevant to common retinal neurodegenerative diseases.


  • Open Access

    MKK4 and MKK7 control degeneration of retinal ganglion cell somas and axons after glaucoma-relevant injury

    by Olivia J. Marola, Stephanie B. Syc-Mazurek, Sarah E. R. Yablonski, Peter G. Shrager, Simon W.M. John, Richard T. Libby

    Glaucoma is characterized by programmed cell death of retinal ganglion cells (RGCs) after axonal injury. Several studies have shown the cell-intrinsic drivers of RGC degeneration act in a compartment-specific manor. Recently, the transcription factors JUN and DDIT3 were identified as critical hubs regulating RGC somal loss after mechanical axonal injury. It is possible somal DDIT3/JUN activity initiates axonal degeneration mechanisms in glaucoma. Alternatively, DDIT3/JUN may act downstream of inciting degenerative mechanisms and only drive RGC somal loss. The MAP2Ks MKK4 and MKK7 control all JNK/JUN activity and can indirectly activate DDIT3. Furthermore, MKK4/7 have been shown to drive RGC axonal degeneration after mechanical axonal injury. The present work investigated whether JUN and DDIT3, or their upstream activators MKK4 and MKK7, control degeneration of RGC axons and somas after glaucoma-relevant injury. Ddit3 / Jun deletion did not prevent axonal degeneration in ocular hypertensive DBA/2J mice but prevented nearly all RGC somal loss. Despite robust somal survival, Ddit3/Jun deletion did not preserve RGC somal viability (as assessed by PERG decline and soma shrinkage) in DBA/2J mice or after glaucoma-relevant mechanical axonal injury. In contrast, Mkk4/7 deletion significantly lessened degeneration of RGC somas and axons, and preserved somal function and size after axonal injury. In summary, activation of MKK4 and MKK7 appears to be the inciting mechanism governing death of the entire RGC after glaucoma-relevant injury; driving death of the RGC soma (likely through activation of DDIT3 and JUN), decline in somal viability, and axonal degeneration via DDIT3/JUN-independent mechanisms.


  • Open Access

    Genetic context modulates aging and degeneration in the murine retina

    by Olivia J. Marola, Michael MacLean, Travis L. Cossette, Cory A. Diemler, Amanda A. Hewes, Alaina M. Reagan, Daniel A. Skelly, Gareth R. Howell

    Background: Age is the principal risk factor for neurodegeneration in both the retina and brain. The retina and brain share many biological properties; thus, insights into retinal aging and degeneration may shed light onto similar processes in the brain. Genetic makeup strongly influences susceptibility to age-related retinal disease. However, studies investigating retinal aging have not sufficiently accounted for genetic diversity. Therefore, examining molecular aging in the retina across different genetic backgrounds will enhance our understanding of human-relevant aging and degeneration in both the retina and brain—potentially improving therapeutic approaches to these debilitating conditions. Methods: Transcriptomics and proteomics were employed to elucidate retinal aging signatures in nine genetically diverse mouse strains (C57BL/6J, 129S1/SvlmJ, NZO/HlLtJ, WSB/EiJ, CAST/EiJ, PWK/PhK, NOD/ShiLtJ, A/J, and BALB/cJ) across lifespan. These data predicted human disease-relevant changes in WSB and NZO strains. Accordingly, B6, WSB and NZO mice were subjected to human-relevant in vivo examinations at 4, 8, 12, and/or 18M, including: slit lamp, fundus imaging, optical coherence tomography, fluorescein angiography, and pattern/full-field electroretinography. Retinal morphology, vascular structure, and cell counts were assessed ex vivo . Results: We identified common molecular aging signatures across the nine mouse strains, which included genes associated with photoreceptor function and immune activation. Genetic background strongly modulated these aging signatures. Analysis of cell type-specific marker genes predicted age-related loss of photoreceptors and retinal ganglion cells (RGCs) in WSB and NZO, respectively. Fundus exams revealed retinitis pigmentosa-relevant pigmentary abnormalities in WSB retinas and diabetic retinopathy (DR)-relevant cotton wool spots and exudates in NZO retinas. Profound photoreceptor dysfunction and loss were confirmed in WSB. Molecular analyses indicated changes in photoreceptor-specific proteins prior to loss, suggesting photoreceptor-intrinsic dysfunction in WSB. In addition, age-associated RGC dysfunction, loss, and concomitant microvascular dysfunction was observed in NZO mice. Proteomic analyses revealed an early reduction in protective antioxidant processes, which may underlie increased susceptibility to DR-relevant pathology in NZO. Conclusions: Genetic context is a strong determinant of retinal aging, and our multi-omics resource can aid in understanding age-related diseases of the eye and brain. Our investigations identified and validated WSB and NZO mice as improved preclinical models relevant to common retinal neurodegenerative diseases.


  • Open Access

    Investigating enhancement of TIE2 activation as a means of preserving blood‐brain barrier integrity and preventing cerebral amyloid angiopathy in Alzheimer’s Disease

    by Olivia J Marola, Kristen D Onos, Michael Maclean, Kelly J Keezer, Gareth R Howell

    Background: Cerebral amyloid angiopathy (CAA) co‐occurs with cognitive impairment and neurodegeneration in Alzheimer’s disease (AD). We have shown wild‐derived WSB/EiJ (WSB) mice transgenic for APP/PS1 robustly developed CAA and are thus a useful tool to investigate the mechanisms driving CAA. It has been hypothesized that loss of blood brain barrier (BBB) integrity causes improper amyloid clearance and vascular deposition. One mechanism by which this is possible is the deactivation (loss of phosphorylation) of endothelial cell TIE2. TIE2 phosphorylation is negatively regulated by endogenous antagonists ANGPT2 and VE‐PTP, which can be manipulated to potentially bolster BBB integrity and prevent CAA. Here, we fully characterize CAA pathogenesis in WSB.APP/PS1 mice and explore the efficacy of enhancing TIE2 phosphorylation to protect from BBB dysfunction and CAA.Method: Male and female WSB mice harboring the APP/PS1 transgene were aged to 4, 6, 8, 14, and 18 months. Brains were histologically assessed for parenchymal plaque deposition and CAA. To investigate the importance of TIE2 inactivation in driving BBB dysfunction in WSB mice, adult WSB and B6 mice were treated with 5mg/kg lipopolysaccharide (LPS; known to induce BBB leakage) or vehicle control. Brains were harvested 16 hours later and bulk RNA‐seq was performed to investigate modulation of Angpt2 expression.Result: Male and female WSB.APP/PS1 mice exhibited significant parenchymal plaque deposition and CAA by 8 months, which was further increased by 14 and 18 months. Furthermore, while expression of Angpt2 was significantly upregulated after LPS treatment in both B6 and WSB compared to vehicle‐treated counterparts, WSB showed a significantly greater increase compared to B6.Conclusion: WSB.APP/PS1 mice develop progressively severe CAA, which may be driven by unique susceptibility to BBB dysfunction. The enhanced elevation of WSB Angpt2 upon LPS treatment may reflect susceptibility of WSB vasculature to BBB degradation and therefore CAA development. Thus, TIE2 phosphorylation will be experimentally elevated in WSB.APP/PS1 mice through Angpt2 heterozygosity and VE‐PTP pharmacological inhibition with AKB‐9778 to determine whether protecting the BBB is a viable strategy to prevent CAA. Furthermore, B6 and WSB.APP/PS1 F2 gene mapping studies will be utilized to identify WSB‐associated alleles driving CAA pathogenesis.

  • Open Access

    Identifying human‐relevant genetic interactors of APOE using genetically diverse mouse strains

    by Kristen D Onos, Kevin J Elk, Asli Uyar, Kelly J Keezer, Olivia J Marola, Rachel Kasper, Ravi S Pandey, Gregory W Carter, Michael Sasner, Gareth R Howell

    Background: APOEe4 is the greatest risk factor for late‐onset Alzheimer’s disease (AD), accounting for ∼30% of genetic risk and significantly decreasing age of onset. APOE is implicated to play central roles across multiple pathways such as neuroinflammation, lipid metabolism and vascular health. Current mechanistic work has introduced humanized APOE alleles in mouse models of AD on a single laboratory mouse strain, C57BL/6J (B6). Recent work from our lab has taken advantage of genetically diverse wild‐derived strains which were captured from different geographical regions and then inbred, thus, their genomes are closer to recapitulating combinations that would exist in the natural world. Here, we seek to identify and validate human‐relevant genetic interactors of APOE within these contexts and in the presence of amyloid.Method: Novel wild‐derived mice were developed by backcrossing the respective strain (PWK/PhJ, WSB/EiJ) to B6.APOEe4 (N5). These were crossed with congenic APP/PS1 carriers, and offspring intercrossed to generate cohorts of 4‐ and 8‐month males and females homozygous for APOEe4, with and without APP/PS1. A cohort of B6.APOEe4 carrying APP/PS1 were also generated for comparison. Neuropathology was assessed along with blood chemistry, and transcriptional profiling was performed on brain hemispheres.Result: Brain transcriptional profiling revealed that APOEe4 had the greatest impact on differential gene expression (dE) in the PWK genetic context at both timepoints, with the strongest effect in females. Comparison with AMP‐AD human‐derived consensus clusters also indicated the broadest overlap when variants were present in the PWK context. Furthermore, APOEe4 genotype was sufficient to cause neuronal damage at 8 months, despite other studies indicating neuronal resilience to amyloid and aging in PWK. In both WSB and B6 carrying APP/PS1, APOEe4 increased the incidence and severity of cerebral amyloid angiopathy (CAA). Further neuropathological assessments are ongoing, and will be correlated with dE.Conclusion: This work highlights the importance of assessing risk alleles for AD in a variety of genetic contexts. We have also created genetically diverse panels of mice that carry humanized amyloid beta and humanized tau in that hope that these strains will provide an improved preclinical platform for therapeutic discovery and testing.

  • Open Access

    Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death

    by Olivia J. Marola, Gareth R. Howell, Richard T. Libby

    Endothelin (EDN, also known as ET) signaling has been suggested to be an important mediator of retinal ganglion cell (RGC) death in glaucoma. Antagonism of EDN receptors (EDNRA and EDNRB, also known as ET-A and ET-B) prevented RGC death in mouse models of chronic ocular hypertension, and intravitreal injection of EDN ligand was sufficient to drive RGC death. However, it remains unclear which cell types EDN ligands directly affect to elicit RGC death. Multiple cell types in the retina and optic nerve express EDNRA and EDNRB and thus could respond to EDN ligands in the context of glaucoma. Here, we systematically deleted Edn receptors from specific cell types to identify the critical EDN receptor mediating RGC death in vivo. Deletion of both Ednra and Ednrb from retinal neurons (including RGCs) and macroglia did not prevent RGC loss after exposure to EDN1 ligands, suggesting EDN1 ligands cause RGC death via an indirect mechanism involving a secondary cell type. Deletion of Ednra from the full body, and then specifically from vascular mural cells, prevented EDN1-induced vasoconstriction and RGC death. Together, these data suggest EDN ligands cause RGC death via a mechanism initiated by vascular mural cells. It is possible RGC death is a consequence of vascular mural cell-induced vasoconstriction and its pathological sequelae. These results highlight the potential importance of neurovascular dysfunction in glaucoma.